PDF
Corrigendum | Open Access
Xiao-Meng Dai, Tao Huang, Sheng-Li Yang, Xiu-Mei Zheng, George G. Chen, Tao Zhang, "Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”", Disease Markers, vol. 2017, Article ID 3765279, 1 page, 2017. https://doi.org/10.1155/2017/3765279
Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
Xiao-Meng Dai
,1 Tao Huang,2 Sheng-Li Yang,1 Xiu-Mei Zheng,1 George G. Chen,3 and Tao Zhang11Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Department of Pediatrics, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430064, China
3Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
In the article titled “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma” [1], affiliation number one was given incorrectly. The corrected affiliation is shown above.
References
- X.-M. Dai, T. Huang, S.-L. Yang, X.-M. Zheng, G. G. Chen, and T. Zhang, “Peritumoral EpCAM is an independent prognostic marker after curative resection of HBV-related hepatocellular carcinoma,” Disease Markers, vol. 2017, Article ID 8495326, 8 pages, 2017. View at: Publisher Site | Google Scholar
Copyright
Copyright © 2017 Xiao-Meng Dai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
